SLC3A1 and nephrolithiasis: Indeed, more than 95% of all carriers of two SLC3A1 or SLC7A9 mutations (genotypes AA, BB, AB) will develop kidney stones in their live but the age of kidney stone formation is difficult to predict and shows a broad intrafamilial variability.